| Literature DB >> 26953250 |
Germano Castelli1, Federica Bruno1, Fabrizio Vitale1, Marinella Roberti2, Claudia Colomba3, Elisa Giacomini4, Laura Guidotti2, Antonio Cascio3, Manlio Tolomeo5.
Abstract
Leishmaniasis are globally widespread parasitic diseases which often leads to death if left untreated. Currently available drugs present different drawbacks, so there is an urgent need to develop new, safe and cost-effective drugs against leishmaniasis. In this study we tested a small library of trans-stilbene and terphenyl derivatives against promastigote, amastigotes and intramacrophage amastigote forms of Leishmania infantum. Two compounds of the series, the trans-stilbene 3 and the terphenyl 11, presented the best activity and safety profiles. Terphenyl 11 showed a leshmanicidal activity higher than pentostam and the ability to induce apoptosis selectively in Leishmania infantum while saving macrophages and primary epithelial cells. Our data indicate that terphenyl compounds, as well as stilbenes, are endowed with leishmanicidal activity, showing potential for further studies in the context of leishmanial therapy.Entities:
Keywords: Leishmaniasis; Programmed cell death; Stilbenes; Terphenyls
Mesh:
Substances:
Year: 2016 PMID: 26953250 DOI: 10.1016/j.exppara.2016.03.007
Source DB: PubMed Journal: Exp Parasitol ISSN: 0014-4894 Impact factor: 2.011